CHCHD2 Human shRNA Plasmid Kit (Locus ID 51142)
CAT#: TL317169
CHCHD2 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 7,740.00
货期*
2周
规格
Cited in 1 publication. |
Product images
经常一起买 (4)
Lateral flow testing sticks used for the semi-quantitative detection of the lentiviral p24 protein, 20 tests
CNY 4,070.00
Specifications
Product Data | |
Product Name | CHCHD2 Human shRNA Plasmid Kit (Locus ID 51142) |
Locus ID | 51142 |
UniProt ID | Q9Y6H1 |
Synonyms | C7orf17; MIX17B; MNRR1; NS2TP; PARK22 |
Vector | pGFP-C-shLenti |
Format | Lentiviral plasmids |
Kit Components | CHCHD2 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector(Gene ID = 51142). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector, TR30021, included for free. |
RefSeq | BC066331, NM_001320327, NM_016139, NM_016139.1, NM_016139.2, NM_016139.3, BC003079, BC015639, BC071985, BC100275, NM_016139.4 |
Summary | The protein encoded by this gene belongs to a class of eukaryotic CX(9)C proteins characterized by four cysteine residues spaced ten amino acids apart from one another. These residues form disulfide linkages that define a CHCH fold. In response to stress, the protein translocates from the mitochondrial intermembrane space to the nucleus where it binds to a highly conserved 13 nucleotide oxygen responsive element in the promoter of cytochrome oxidase 4I2, a subunit of the terminal enzyme of the electron transport chain. In concert with recombination signal sequence-binding protein J, binding of this protein activates the oxygen responsive element at four percent oxygen. In addition, it has been shown that this protein is a negative regulator of mitochondria-mediated apoptosis. In response to apoptotic stimuli, mitochondrial levels of this protein decrease, allowing BCL2-associated X protein to oligomerize and activate the caspase cascade. Pseudogenes of this gene are found on multiple chromosomes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (1)
The use of this RNAi has been cited in the following citations: |
---|
FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N(6)-Methyladenosine RNA Demethylase
,Li, Z;Weng, H;Su, R;Weng, X;Zuo, Z;Li, C;Huang, H;Nachtergaele, S;Dong, L;Hu, C;Qin, X;Tang, L;Wang, Y;Hong, GM;Huang, H;Wang, X;Chen, P;Gurbuxani, S;Arnovitz, S;Li, Y;Li, S;Strong, J;Neilly, MB;Larson, RA;Jiang, X;Zhang, P;Jin, J;He, C;Chen, J;,
Cancer Cell
,PubMed ID 28017614
[CHCHD2]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...